Observational study / 2020
Low serum B12 was linked to higher all-cause and cardiovascular mortality, while high serum B12 was linked to increased cardiovascular mortality.
Using NHANES data linked to the National Death Index over a median follow-up of 109 months, researchers evaluated associations between serum B12, vitamin B12 supplement intake, and mortality. Low serum B12 (< 140 pmol/l) was associated with increased all-cause (HR 1.39, 95% CI 1.08-1.78) and cardiovascular mortality (HR 1.64, 95% CI 1.08-2.47). High serum B12 (> 700 pmol/l) was associated only with increased cardiovascular mortality (HR 1.45, 95% CI 1.01-2.06). Vitamin B12 supplement intake was not associated with mortality after adjustment for comorbidity.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 24,262 NHANES participants (mean age 48 years; 50.1% males)
- What was measured
- All-cause mortality, cardiovascular mortality, and cancer-related mortality
THE PAPER
Relationship between serum B12 concentrations and mortality: experience in NHANES.
Wolffenbuttel BHR, Heiner-Fokkema MR, Green R, Gans ROB. BMC Med, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.